Umeclidinium Vilanterol

8 Topics Found
Umeclidinium + Vilanterol Drug Index

Vilanterol (INN, USAN) is an ultra-long-acting β2 adrenoreceptor agonist (ultra-LABA), which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).[1][2]. The combination is also approved for the treatment of asthma in Europe, Japan[3] and New Zealand.[4] Vilanterol is available in following combinations: ...

Fluticasone Furoate + Umeclidinium + Vilanterol Drug Index

Vilanterol (INN, USAN) is an ultra-long-acting β2 adrenoreceptor agonist (ultra-LABA), which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).[1][2]. The combination is also approved for the treatment of asthma in Europe, Japan[3] and New Zealand.[4] Vilanterol is available in following combinations: ...

Umeclidinium Bromide Drug Index

Umeclidinium bromide (trade name Incruse Ellipta) is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD).[1] It is also approved for this indication in combination with vilanterol (as umeclidinium bromide/vilanterol)[2][3] and also as a triple-therapy combination as fluticasone furoate/umeclidinium bromide/vilanterol.[4] It is on the World Health Organization...

Incruse Ellipta Umeclidinium Bromide

Umeclidinium bromide (trade name Incruse Ellipta) is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD).[1] It is also approved for this indication in combination with vilanterol (as umeclidinium bromide/vilanterol)[2][3] and also as a triple-therapy combination as fluticasone furoate/umeclidinium bromide/vilanterol.[4] It is on the World Health Organization...

Does anyone know if the chances of getting osteoporosis from taking Trelegy are increased? ## This medication contains the active ingredients Fluticasone, Umeclidinium, and Vilanterol, and it has been known to decrease bone density, and cause fractures as side effects. Ref: Trelegy Information Other side effects may include nausea, changes in taste, back pain, cough, and headache. Do you already suffer from osteoporosis?

1 REPLY Filed under Fluticasone
NDC 0173-0869 NDC Database

Anoro Ellipta Respiratory (Inhalation) Powder by Glaxosmithkline LLC ## Package Codes: 0173-0869-06, 0173-0869-10, 0173-0869-61 ## Active Ingredients: Umeclidinium Bromide + Vilanterol Trifenatate

NDC 0173-0887 NDC Database

Trelegy Ellipta Respiratory (Inhalation) Powder by Glaxosmithkline LLC ## Package Codes: 0173-0887-10, 0173-0887-14, 0173-0887-61 ## Active Ingredients: Fluticasone Furoate + Umeclidinium Bromide + Vilanterol Trifenatate

NDC 0173-0893 NDC Database

Trelegy Ellipta Respiratory (Inhalation) Powder by Glaxosmithkline LLC ## Package Codes: 0173-0893-10, 0173-0893-14, 0173-0893-61 ## Active Ingredients: Fluticasone Furoate + Umeclidinium Bromide + Vilanterol Trifenatate

Can't find what you're looking for?